{"title":"心血管手术后托伐普坦治疗的最佳患者选择和治疗时机-回复。","authors":"Yasuhiro Matsuda, Tadaaki Koyama","doi":"10.1253/circrep.CR-23-0014","DOIUrl":null,"url":null,"abstract":"predictor of the response to tolvaptan.6 In future, if possible, we would like to conduct a comparative study in a group of patients with poor renal function. However there is a high possibility that this group of patients will be treated with a combination of multiple drugs, such as other diuretics and carperitide, and it will therefore be difficult to evaluate the effects of tolvaptan alone.","PeriodicalId":10276,"journal":{"name":"Circulation Reports","volume":"5 3","pages":"102"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/2b/circrep-5-102.PMC9992506.pdf","citationCount":"0","resultStr":"{\"title\":\"Optimal Patient Selection and Treatment Timing for Tolvaptan Therapy Following Cardiovascular Surgery - Reply.\",\"authors\":\"Yasuhiro Matsuda, Tadaaki Koyama\",\"doi\":\"10.1253/circrep.CR-23-0014\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"predictor of the response to tolvaptan.6 In future, if possible, we would like to conduct a comparative study in a group of patients with poor renal function. However there is a high possibility that this group of patients will be treated with a combination of multiple drugs, such as other diuretics and carperitide, and it will therefore be difficult to evaluate the effects of tolvaptan alone.\",\"PeriodicalId\":10276,\"journal\":{\"name\":\"Circulation Reports\",\"volume\":\"5 3\",\"pages\":\"102\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/36/2b/circrep-5-102.PMC9992506.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Circulation Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1253/circrep.CR-23-0014\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Circulation Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1253/circrep.CR-23-0014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Optimal Patient Selection and Treatment Timing for Tolvaptan Therapy Following Cardiovascular Surgery - Reply.
predictor of the response to tolvaptan.6 In future, if possible, we would like to conduct a comparative study in a group of patients with poor renal function. However there is a high possibility that this group of patients will be treated with a combination of multiple drugs, such as other diuretics and carperitide, and it will therefore be difficult to evaluate the effects of tolvaptan alone.